A detailed history of Paces Ferry Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Paces Ferry Wealth Advisors, LLC holds 2,210 shares of ABBV stock, worth $445,315. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,210
Previous 2,356 6.2%
Holding current value
$445,315
Previous $429,000 11.66%
% of portfolio
0.23%
Previous 0.28%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $22,599 - $26,390
-146 Reduced 6.2%
2,210 $379,000
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $18,539 - $21,123
-116 Reduced 4.69%
2,356 $429,000
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $40,316 - $45,406
293 Added 13.45%
2,472 $383,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $33,798 - $39,126
253 Added 13.14%
2,179 $324,000
Q2 2023

Jul 28, 2023

SELL
$132.51 - $164.9 $42,800 - $53,262
-323 Reduced 14.36%
1,926 $259,000
Q1 2023

Apr 24, 2023

BUY
$144.61 - $166.54 $7,953 - $9,159
55 Added 2.51%
2,249 $358,000
Q4 2022

Jan 23, 2023

SELL
$138.31 - $165.87 $3,319 - $3,980
-24 Reduced 1.08%
2,194 $0
Q3 2022

Oct 13, 2022

SELL
$134.21 - $153.93 $6,844 - $7,850
-51 Reduced 2.25%
2,218 $298,000
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $10,321 - $13,122
75 Added 3.42%
2,269 $348,000
Q1 2022

Apr 20, 2022

SELL
$131.98 - $163.75 $1,055 - $1,310
-8 Reduced 0.36%
2,194 $356,000
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $10,850 - $13,728
-101 Reduced 4.39%
2,202 $298,000
Q3 2021

Oct 29, 2021

SELL
$106.4 - $120.78 $1,808 - $2,053
-17 Reduced 0.73%
2,303 $248,000
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $6,417 - $7,149
61 Added 2.7%
2,320 $261,000
Q1 2021

May 19, 2021

BUY
$102.3 - $112.62 $231,095 - $254,408
2,259 New
2,259 $244,000
Q4 2020

Mar 05, 2021

SELL
$80.49 - $108.67 $113,973 - $153,876
-1,416 Closed
0 $0
Q3 2020

Nov 19, 2020

BUY
$85.91 - $100.83 $121,648 - $142,775
1,416 New
1,416 $124,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $356B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Paces Ferry Wealth Advisors, LLC Portfolio

Follow Paces Ferry Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paces Ferry Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paces Ferry Wealth Advisors, LLC with notifications on news.